- $2.86bn
- $7.03bn
- $1.63bn
- 69
- 61
- 90
- 85
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,498 | 1,482 | 1,619 | 1,683 | 1,634 |
Cost of Revenue | |||||
Gross Profit | 507 | 545 | 546 | 579 | 604 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,107 | 1,414 | 1,382 | 1,258 | 1,124 |
Operating Profit | 391 | 67.4 | 236 | 425 | 510 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 212 | -196 | 42.1 | 226 | 279 |
Provision for Income Taxes | |||||
Net Income After Taxes | 207 | -199 | 38.2 | 223 | 274 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -106 | -199 | 38.2 | 223 | 274 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -248 | -344 | -108 | 39.7 | 84.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.65 | -0.964 | 0.575 | 0.625 | 0.379 |
Dividends per Share |